Interferon lambda therapy for treatment of respiratory diseases

Details Interferon lambda therapy for treatment of respiratory diseases Interferon lambda therapy for treatment of respiratory diseases

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61M 15/00 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2622016

The present invention relates to use of one or more interferon lambdas (IFN- .lambda.s), also known as IL-29 and IL28a/b, for alleviating or preventing viral-induced exacerbation of a respiratory disorder, especially for example exacerbation of asthma arising from viral infection, most commonly rhino virus infection.

La présente invention concerne l'utilisation d'un ou plusieurs interférons lambda (IFN-.lambda.), également connus sous le nom d'IL-29 et d'IL-28a/b, pour atténuer ou prévenir une exacerbation d'origine virale d'un trouble respiratoire, telle qu'une exacerbation de l'asthme liée à une infection virale, et notamment à une infection à rhinovirus.

Affiliated with

Also associated with

Rating

Interferon lambda therapy for treatment of respiratory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon lambda therapy for treatment of respiratory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon lambda therapy for treatment of respiratory diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1729171